AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020
Dec 31, 2020
30583_dirs_2020-12-30_216b1200-3b35-49be-8385-3436bfabd5a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-07-09
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-09 | Common Stock | G | 425 | — | Disposed | 247533 | Indirect |
| 2020-12-28 | Common Stock | S | 1500 | $88.77 | Disposed | 297052 | Direct |
| 2020-12-29 | Common Stock | S | 1500 | $88.18 | Disposed | 295552 | Direct |
Footnotes
F1: On July 9, 2020 the reporting person gifted 425 shares to a charitable organization.
F2: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19